Zacks Investment Research upgraded shares of Sysmex Corp (NASDAQ:SSMXY) from a sell rating to a hold rating in a research note issued to investors on Wednesday, May 3rd.
According to Zacks, “Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company’s product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. “
Sysmex Corp (NASDAQ:SSMXY) traded down 0.95% during trading on Wednesday, hitting $28.14. 3,315 shares of the stock traded hands. The firm has a 50-day moving average price of $30.48 and a 200 day moving average price of $29.86. The company has a market cap of $11.71 billion and a P/E ratio of 32.14. Sysmex Corp has a 52-week low of $26.58 and a 52-week high of $37.88.
COPYRIGHT VIOLATION NOTICE: “Sysmex Corp (SSMXY) Stock Rating Upgraded by Zacks Investment Research” was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2017/05/19/sysmex-corp-ssmxy-lifted-to-hold-at-zacks-investment-research-updated.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sysmex Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex Corp and related companies with MarketBeat.com's FREE daily email newsletter.